April 22, 2024

GWS5000

Make Every Business

HIMSSCast: The future of telehealth reimbursement

Restrictions and uncertainty about telehealth reimbursement have often been an impediment to adoption. In the course of the COVID-19 unexpected emergency, that burden was eased fairly, but now the new standard is starting off to just take form. What barriers even now continue to be to telehealth reimbursement, and how could possibly they be defeat? To answer that dilemma, host Jonah Comstock and Healthcare Finance Information Handling Editor Susan Morse welcome McKinsey & Corporation associates Oleg Bestsennyy and Gunjan Khanna.

This episode is brought to you by BlueJeans.

Like what you listen to? Subscribe to the podcast on Apple Podcasts, Spotify or Google Play!

 

Chatting factors:

  • COVID-19 reimbursement adjustments and which of them will stick about
  • Adoption classes figured out and how they’ll influence reimbursement policy
  • Holistic tele-treatment and treatment past the movie go to
  • Influence of new entrants and innovation on the place
  • Is cost-for-company reimbursement an innovation blocker?
  • Reimbursement for distinct telehealth modalities
  • Time to direct fairly than comply with for personal payers?
  • The even now-unresolved dilemma of induced utilization
  • The rise of benefit-dependent treatment and hybrid treatment designs
  • Telehealth reimbursement and health fairness
  • How are clients experience about telehealth now?
  • Ultimate feelings: the future of telehealth reimbursement

Much more about this episode:

Report displays ‘vast improvement’ in point out telehealth reimbursement policies

COVID-19 may permanently alter the telehealth landscape, from reimbursement to utilization

Telehealth reimbursement parity spurs insurance provider problems of overutilization

CMS will reimburse for 11 new telehealth products and services for the duration of the general public health unexpected emergency

Congressional action is necessary for telehealth not to return to a rural reward, Seema Verma states

Telehealth: A quarter-trillion-dollar put up-COVID-19 truth? (McKinsey)

COVID-19 Consumer Healthcare Insights: What 2021 may hold (McKinsey)

How COVID-19 has changed the way US consumers believe about healthcare (McKinsey)